Bad blood is brewing among some major players in the weight loss world. Novo Nordisk, the creator of Ozempic and Wegovy, cut short its partnership with telehealth company Hims & Hers Health Inc. over allegations that the latter is still trying to mass-market cheaper versions of the GLP-1 drugs. Bloomberg News reported the abrupt dissolution […]
The Ugly Side of Weight-Loss Drugs: Rotten Breath, Damaged Teeth, and Dry Mouth
Ozempic and Wegovy have been hailed as wonder drugs when it comes to weight loss. But as the drug has become more widely used, a number of unintended side-effects have become apparent—with the weight loss drug affecting the appearance of everything from your butt to your feet. “Ozempic face” is another commonly reported consequences of […]
Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that, amidst a recent downturn in the company’s stock, Lars Fruergaard Jørgensen would soon be stepping down as its top executive and the board would […]
People on Ozempic Are Drinking Way Less
Ozempic and similar drugs aren’t just for weight loss, more and more research is finding. New data is the latest to show that GLP-1 medications help lower people’s alcohol consumption, too. Scientists in Ireland and Saudi Arabia conducted the study, which involved around 200 patients who were prescribed GLP-1 drugs to manage their obesity. They […]
Semaglutide Shows Major Promise for Treating Serious Liver Disease
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, is poised to add to its growing list of medical uses. In a large-scale clinical trial published today, semaglutide was found to be effective at treating a severe and relatively common form of liver disease. Researchers in the U.S. and the U.K. led the Phase […]
Trump Is Promising to Lower Drug Prices. Don’t Count on It
The Trump administration pledged this week to substantially reduce the high prices Americans commonly pay for their prescription drugs. It’s a promise that will undoubtedly come up short. On Tuesday, President Donald Trump signed an executive order laying out the steps that the federal government, via the Department of Health and Human Services, is planning […]
How Ozempic and Similar Drugs Are Quietly Rewriting America’s Eating Habits
Research out this week might help you plan your own version of the Ozempic diet, with the results of a survey revealing the foods that people tend to avoid, or eat less of, once they start taking GLP-1 drugs. Scientists at the Arkansas Agricultural Experiment Station led the study, a survey of past, current, and […]
Scientists Discover Potential Ozempic Rival That Could Help People Lose Weight With Less Nausea
Wegovy, eat your heart out. In a new research paper, scientists say they’ve discovered a naturally occurring hormone that might help people lose weight while avoiding the side effects commonly associated with semaglutide (the active ingredient in Ozempic and Wegovy) and similar drugs. A team of researchers at Stanford Medicine conducted the study, published last […]
Does Ozempic Really Cause Thyroid Cancer? What the Science Actually Says
For all the buzz surrounding Ozempic and similar GLP-1 drugs for weight loss, there are also plenty of concerns about potential serious or long-term side effects. Among the scariest of these fears is that GLP-1 drugs may cause certain types of thyroid cancer. The risk is relevant enough that the Food and Drug Administration has […]
Eye Doctors Are Finding New Links Between Ozempic and Vision Problems
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several people who developed eye conditions soon after they began taking semaglutide and similar medications. Eye doctors at the University of Utah Health and elsewhere published the research, which describes several cases of vision complications possibly […]